Alector

Alector is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia. They leverage insights from human genetics, neuroscience, and immunology to create treatments that aim to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. The company also develops a proprietary Alector Brain Carrier (ABC) platform to improve drug delivery across the blood-brain barrier.